Celares GmbH is a Contract Development and Manufacturing Organisation (CDMO) that specializes in the development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. With a focus on customised conjugation solutions, Celares has established expertise in the development of PEGylated biomolecules and multiple antibody-related services, demonstrating a commitment to advancing pharmaceutical and biopharmaceutical innovations.

Services include:
– Accelerated Stability Studies
– Analytical Services
– Bioanalytical Services
– Biologics
– Process Development
– Biosimilars
– Contract Development and Manufacturing (CDMO)
– Contract Manufacturing (CMO)
– Contract Research (CRO)
– Custom Synthesis
– Feasibility Studies
– Process Validation Studies
– Stability Studies
– APIs (Active Pharmaceutical Ingredients)

Celares is dedicated to supporting the pharmaceutical industry with high-quality solutions tailored to meet client needs. For more information, please visit celares.com.